NY A06923

Requires all health insurance policies providing medical or major medical coverage to include continuous blood glucose monitors in their mandated diabetes equipment coverage, specifically naming Dexcom devices as an example

Expands coverage requirements from diabetes alone to include "diabetes and other sugar disorders"

Removes age-based restrictions by mandating coverage "regardless of the patient's age," ensuring children have access to continuous glucose monitoring devices

Applies to individual policies, group/blanket policies, and health service corporations under sections 3216, 3221, and 4303 of the insurance law

Takes effect 90 days after becoming law and applies to policies issued, renewed, amended, modified, or altered on or after that date